CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2019	Dec. 31, 2018
CURRENT ASSETS
Cash and cash equivalents	$ 99,543	$ 89,132
Research supplies	47,402	57,785
Grant funds receivable	34,060	37,562
Prepaid expenses and other current assets	53,949	64,543
Total current assets	234,954	249,022
Property and equipment, net	3,483	4,929
Total Assets	238,437	253,951
CURRENT LIABILITIES
Accounts payable and accrued liabilities	109,585	127,217
Total current liabilities	109,585	127,217
LONG TERM LIABILITIES
Accrued licensing fees	639,290	652,359
Other liabilities	142,438	145,396
Total long term liabilities	781,728	797,755
Total liabilities	891,313	924,972
COMMITMENTS AND CONTINGENCIES (Note 8)
STOCKHOLDERS' DEFICIT
Common stock, par value $0.001 per share; 300,000,000 shares authorized; 24,879,350 and 24,379,350 shares issued and outstanding at December 31, 2019 and 2018, respectively	24,880	24,380
Additional paid-in capital	9,385,584	9,144,464
Accumulated other comprehensive loss	(33,613)	(31,231)
Accumulated deficit	(10,030,731)	(9,812,564)
Total Proteo, Inc. Stockholders' Deficit	(652,876)	(674,127)
Noncontrolling Interest	0	3,106
Total stockholders' deficit	(652,876)	(671,021)
Total liabilities and stockholders' deficit	238,437	253,951
Series A Preferred Stock [Member]
STOCKHOLDERS' DEFICIT
Non-voting preferred stock, par value $0.001 per share; 10,000,000 shares authorized; Series A, 723,590 shares issued and outstanding at December 31, 2019 and 2018; Series B-1, 120,000 shares and 100,000 shares issued and outstanding at December 31, 2019 and 2018, respectively; Series B-2, 159,800 shares and 0 shares issued and outstanding at December 31, 2019 and 2018, respectively	724	724
Series B-1 Preferred Stock [Member]
STOCKHOLDERS' DEFICIT
Non-voting preferred stock, par value $0.001 per share; 10,000,000 shares authorized; Series A, 723,590 shares issued and outstanding at December 31, 2019 and 2018; Series B-1, 120,000 shares and 100,000 shares issued and outstanding at December 31, 2019 and 2018, respectively; Series B-2, 159,800 shares and 0 shares issued and outstanding at December 31, 2019 and 2018, respectively	120	100
Series B-2 Preferred Stock [Member]
STOCKHOLDERS' DEFICIT
Non-voting preferred stock, par value $0.001 per share; 10,000,000 shares authorized; Series A, 723,590 shares issued and outstanding at December 31, 2019 and 2018; Series B-1, 120,000 shares and 100,000 shares issued and outstanding at December 31, 2019 and 2018, respectively; Series B-2, 159,800 shares and 0 shares issued and outstanding at December 31, 2019 and 2018, respectively	$ 160	$ 0